|
ANKLE2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.07234229776532E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.02855526715484E-12 |
| Normal-vs-Stage2 |
8.217000E-04 |
| Normal-vs-Stage3 |
1.54790000039817E-07 |
| Normal-vs-Stage4 |
9.47629996694843E-09 |
| Stage1-vs-Stage2 |
6.103000E-01 |
| Stage1-vs-Stage3 |
3.916600E-01 |
| Stage1-vs-Stage4 |
3.366800E-01 |
| Stage2-vs-Stage3 |
9.839600E-01 |
| Stage2-vs-Stage4 |
2.831400E-01 |
| Stage3-vs-Stage4 |
1.406440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89115390014649E-12 |
| Normal-vs-AfricanAmerican |
1.121880E-03 |
| Normal-vs-Asian |
1.049250E-01 |
| Caucasian-vs-AfricanAmerican |
1.395830E-01 |
| Caucasian-vs-Asian |
8.658400E-01 |
| AfricanAmerican-vs-Asian |
4.581600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.30868665798789E-12 |
| Normal-vs-Female |
2.94310020798605E-10 |
| Male-vs-Female |
5.622400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.856700E-03 |
| Normal-vs-Age(41-60Yrs) |
3.49653639375447E-12 |
| Normal-vs-Age(61-80Yrs) |
5.57529578060212E-11 |
| Normal-vs-Age(81-100Yrs) |
2.046200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.251400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.979400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.477600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.484800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.760200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.713600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.973500E-04 |
| Normal-vs-Grade 2 |
2.54751775230488E-12 |
| Normal-vs-Grade 3 |
2.7743000119429E-09 |
| Normal-vs-Grade 4 |
1.60609999966255E-07 |
| Grade 1-vs-Grade 2 |
6.890600E-01 |
| Grade 1-vs-Grade 3 |
8.065600E-01 |
| Grade 1-vs-Grade 4 |
4.506000E-01 |
| Grade 2-vs-Grade 3 |
2.704000E-01 |
| Grade 2-vs-Grade 4 |
5.339200E-01 |
| Grade 3-vs-Grade 4 |
1.766440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.67989955279779E-10 |
| Normal-vs-ccB subtype |
1.03669961504238E-10 |
| ccA subtype-vs-ccB subtype |
2.097000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.13390449544227E-11 |
| Normal-vs-N1 |
2.722600E-03 |
| N0-vs-N1 |
9.742400E-02 |
|
|
